Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)
Publication date
2023-01-27
Authors
Ismail, R K
Schramel, F M N H
van Dartel, M
Pasmooij, A M G
der Welle, C M Cramer-van
Hilarius, D L
de Boer, Anthonius
Wouters, M W J M
van de Garde, Ewoudt M.W.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by
Abstract
Following publication of the original article [1], the authors requested to correct the word “first-line” to “second-line” in the article title. The original article has been updated.
Keywords
Citation
Ismail, R K, Schramel, F M N H, van Dartel, M, Pasmooij, A M G, der Welle, C M C, Hilarius, D L, de Boer, A, Wouters, M W J M & van de Garde, E M W 2023, 'Correction : Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC (BMC Medical Research Methodology, (2023), 23, 1, (1), 10.1186/s12874-022-01760-0)', BMC Medical Research Methodology, vol. 23, no. 1, 26. https://doi.org/10.1186/s12874-023-01850-7